(Q37085041)

English

Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis

scientific article published on 11 July 2016

Statements

Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis (English)
11 July 2016

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit